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Abstract
Background: Tumors of the skull base pose unique challenges to radiosurgical treatment because
of their irregular shapes, proximity to critical structures and variable tumor volumes. In this study,
we investigate whether acceptable treatment plans with excellent conformity and homogeneity can
be generated for complex skull base tumors using the Cyberknife® radiosurgical system.
Methods:  At Georgetown University Hospital from March 2002 through May 2005, the
CyberKnife® was used to treat 80 patients with 82 base of skull lesions. Tumors were classified as
simple or complex based on their proximity to adjacent critical structures. All planning and
treatments were performed by the same radiosurgery team with the goal of minimizing dosage to
adjacent critical structures and maximizing target coverage. Treatments were fractionated to allow
for safer delivery of radiation to both large tumors and tumors in close proximity to critical
structures.
Results: The CyberKnife® treatment planning system was capable of generating highly conformal
and homogeneous plans for complex skull base tumors. The treatment planning parameters did not
significantly vary between spherical and non-spherical target volumes. The treatment parameters
obtained from the plans of the complex base of skull group, including new conformity index,
homogeneity index and percentage tumor coverage, were not significantly different from those of
the simple group.
Conclusion: Our data indicate that CyberKnife® treatment plans with excellent homogeneity,
conformity and percent target coverage can be obtained for complex skull base tumors. Longer
follow-up will be required to determine the safety and efficacy of fractionated treatment of these
lesions with this radiosurgical system.
Background
Lesions of the base of skull are typically slow growing, but
potentially morbid tumors [1]. They rarely metastasize
making local control the primary determinant of long-
term survival [2]. Although surgical resection may still be
the treatment "gold-standard" [3,4], radiosurgery is an
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appropriate treatment option for many patients [5]. How-
ever, single-fraction radiosurgical treatment may be diffi-
cult because of the potentially large size and irregular
shapes of these tumors. Their proximity to critical struc-
tures also leads to a risk of radiation-induced, long-term,
neurological complication [6].
The CyberKnife® is a newly FDA approved radiosurgical
devise for the treatment of brain lesions. Unlike the
LINAC and Gamma Knife, the CyberKnife® is an image-
guided, frameless radiosurgery system. Treatment is deliv-
ered by a linear accelerator mounted on a flexible robotic
arm. Several-hundred treatment beams are chosen out of
a repertoire of greater than one thousand possible beam
directions using inverse treatment planning. These beams
are delivered in a non-isocentric manner via circular colli-
mators of varying size without intensity modulation.
Non-isocentric treatment allows for simultaneous irradia-
tion of multiple lesions. The lack of a requirement for the
use of a head-frame allows for staged treatment. Since the
planning system has access to a large number of potential
non-isocentric beams, the CyberKnife® should theoreti-
cally be able to deliver a highly conformal, uniform dose
with steep dose gradients [7]. Therefore, treatment with
the CyberKnife® radiosurgical system should minimize
toxicity to surrounding structures. When compared to
commonly used radiosurgical devices, such as the Gamma
Knife, linear-accelerator based stereotactic radiosurgery
systems with multiple arcs (LINAC), or intensity modu-
lated radiation therapy, dosimetric studies of ellipsoid
phantoms have shown that the CyberKnife® radiosurgical
system has the best homogeneity within the target volume
and comparable conformity [8].
A dose-volume histogram (DVH) is the tool most com-
monly used to compare radiosurgical plans. Unfortu-
nately, the large volume of data in these histograms does
not allow for simple differentiation between multiple
plans and systems [9,10]. Thus, an effort has been made
to determine simple measurements for plan optimization.
A conformity index is a single measure of how well the
treatment dose distribution of a specific radiation treat-
ment plan conforms to the size and shape of the target
volume. In general, the conformity index of a given radio-
surgical plan is dependent on target shape [11], target vol-
ume [9], collimator size [12], type of collimation (circular
vs multileaf) and radiosurgical delivery system.
The new conformity index (NCI) and homogeneity index
(HI) allow for the quick and simple comparison of differ-
ent radiosurgical treatment plans, whether within the
same radiosurgical system, or across diverse systems such
as between the LINAC and Gamma Knife [13]. Conform-
ity indices have been reported in the literature, ranging
from 1.0 to 3.0 for varying radiosurgical systems [14-18].
Typically, multiple iso-center plans generated with the
Gamma Knife have homogeneity indices (HI) of 2.0 to
3.0 while the LINAC plans generate homogeneity indices
(HI) of 1.0 to 1.2 [17]. The significance of these differ-
ences between systems is controversial.
We determined the NCI and HI for the first 82 base of
skull lesions treated at Georgetown University Hospital
using the CyberKnife® radiosurgical system (Accuray, Sun-
nyvale, CA). We undertook this study to determine the
effect of target shape, target volume and proximity to crit-
ical structures on radiosurgical treatment parameters. This
is the first study that we are aware of that investigates these
parameters in patients treated with the CyberKnife® radio-
surgery system.
Patients and methods
Patient population
We performed a retrospective review of 262 patients with
intracranial tumors, who were treated with CyberKnife®
stereotactic radiosurgery at Georgetown University Hospi-
tal between March 2002 and May 2005. Eighty-one
patients were classified to have tumors of the skull base
resulting in a total of 84 treated lesions. Thirty-three per-
cent of these lesions had been previously irradiated. One
patient was excluded from analysis because two tumor
volumes were treated simultaneously making it impossi-
ble to calculate indices for each individual lesion.
Of the remaining lesions, 46 were categorized into the
complex, skull base tumor group. A complex skull base
tumor was defined as one that completely encircles, par-
tially circumscribes, or directly contacts the brainstem,
optic chiasm, hypophysis, or cranial nerves with meaning-
ful remaining function. This complex tumor group con-
sisted of 18 men and 26 women, with a median age of 53
(range: 29 – 88). These tumors were further categorized by
histopathology as follows: 21 meningiomas, 6 metastatic
tumors, 8 schwannomas, 7 pituitary adenomas, 1 chor-
doma, 2 sarcomas, and 1 glioma. The median tumor size
was 7.27 cc (range: 0.62 – 98.3 cc) (Table 1 &2).
The data from the group with complex skull base tumors
were compared with data from two control groups. The
first group consisted of 36 patients with skull base tumors
that were classified as simple. Although still located in the
region of the skull base, tumors in this group had at least
a 2 mm separation from the nearest critical structure. This
group consisted of 16 men and 20 women, with a median
age of 55 (range: 17 – 18). These tumors were also catego-
rized by histopathology as follows: 5 meningiomas, 13
metastatic tumors, 10 schwannomas, 3 pituitary adeno-
mas, 1 chordoma, 2 sarcomas, and 2 malignant gliomas.
The median tumor size in this group was 8.83 cc (range:
0.19 – 206.3 cc) (Table 1 &2).Radiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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A second control group used for comparison consisted of
43 patients with metastatic tumors of the cerebral and cer-
ebellar hemispheres. These lesions represented volumes
that were spherical, with smooth borders, and relatively
distant from critical neurovascular structures. This group
consisted of 23 men and 20 women, with a median age of
58 (range: 21 – 85). These tumors were further catego-
rized by histopatholgy as 33 metastatic carcinomas and 10
melanomas. The median tumor size in this group was
1.43 cc (range: 0.12 – 66 cc) (Table 1 &2).
Radiosurgical treatment planning
The basic technical aspects of CyberKnife® radiosurgery for
cranial tumors have been described in detail (CyberKnife®
Radiosurgery, A Practical Guide). Briefly, the patient was
placed in a supine position on a vacuum bag and a malle-
able thermoplastic mask was molded to the head and
attached to the head support. Thin-sliced (1.25 mm)
high-resolution CT images were obtained through the
region of interest with the patient in the treatment posi-
tion. Target volumes and critical structures were deline-
Table 2: Skull Base Tumor Characteristics
Control Group I (simple) (n = 36) Control Group II (metastases) (n = 43) Study Group (complex) (n = 46)
Volume (cc)
Min 0.19 0.12 0.62
Max 206.3 66 98.3
Mean 45.61 4.87 12.6
Median 8.83 1.43 7.27
Histology
Carcinomas 13 33 4
Chordoma 1 0 1
Gliomas 0 0 1
Malignant Gliomas 2 0 0
Melanoma 0 10 2
Meningioma 5 0 21
Pituitary Adenoma 3 0 7
Sarcomas 2 0 2
Schwannoma (not VIII) 0 0 4
Vestibular Schwannoma 10 0 4
Location
Cavernous Sinus 2 0 15
CP Angle/IAC 12 0 6
Foramen Magnum 0 0 4
Nasopharynx 4 0 0
Orbital Apex/Parasellar 3 0 5
Paranasal Sinus 4 0 0
Petroclival 3 0 7
Sellar 3 0 7
Cerebral Hemishpere 1 34 0
Thalamus/Hypothalamus 0 2 1
Cerebellum 0 7 0
Other* 4 0 1
* Pons, mandible, infratemporal fossa
Table 1: Patient Characteristics
Control Group I (simple) Control Group II (metastases) Study Group (complex)
Number of Patients 36 43 44
Number of Lesions 36 43 46
Male 16 23 18
Female 20 20 26
Age
Min 17 21 29
Max 81 85 88
Mean 53 57 55
Median 55 58 53Radiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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ated by the treating neurosurgeon. The treating
neurosurgeon and radiation oncologist determined the
minimal tumor margin dose of the target volume and the
treatment isodose. This discussion was influenced by var-
ious factors, including previous radiation to the area,
tumor volume, and extent of contact and compression of
critical neurological structures. In most cases, the dose was
prescribed to the isodose surface that encompassed the
margin of the tumor. Twelve collimator sizes are available
with the CyberKnife® radiosurgical system ranging from 5
mm to 60 mm. In general, a collimator size less than the
maximum length of the prescribed target volume (PTV)
was chosen for treatment planning [12]. An inverse plan-
ning method with non-isocenteric technique was used for
all cases. The treating physician and physicist input the
specific treatment criteria, limiting the maximum dose to
structures such as the optic chiasm and brainstem. The
majority of the treatments were given in five fractions. In
general, for non-previously treated cases, treatment plans
were deemed acceptable if the maximum dose to critical
structures was less than 2000 cGy in five fractions. Non-
anatomical dose constraint structures were commonly
incorporated to aid the optimization process in minimiz-
ing the dose to critical structures. The planning software
calculated the optimal solution for treatment. The DVH of
each plan was evaluated until an acceptable plan was gen-
erated.
Treatment planning parameters
Target volume
Target volume was defined as the volume contoured on
the planning CT scan by the treating neurosurgeon. No
margin was added to the target volume. In this study,
there was no limit set on the treatable target volumes.
Homogeneity Index
The homogeneity index (HI) describes the uniformity of
dose within a treated target volume, and is directly calcu-
lated from the prescription isodose line chosen to cover
the margin of the tumor:
New Conformity Index
The new conformity index (NCI) as formulated by Pad-
dick [13], and modified by Nakamura [16] describes the
degree to which the prescribed isodose volume conforms
to the shape and size of the target volume. It also takes
into account avoidance of surrounding normal tissue.
Percent Target Coverage
PTC = The percentage of the target volume covered by the
prescription isodose.
Radiosurgical treatment delivery
Image-guided radiosurgery was employed to eliminate the
need for stereotactic frame fixation. Using computed tom-
ography planning, target volume locations were related to
radiographic landmarks of the cranium. With the assump-
tion that the target position is fixed within the cranium,
cranial tracking allows for anatomy based tracking rela-
tively independent of patient's daily setup. Position verifi-
cation was validated several times per minute during
treatment using paired, orthogonal, x-ray images.
Statistical analysis
Chi-square test or two-sample t-test was used to test the
distributions of the characteristics between the simple and
complex groups. To assess the association between radia-
tion treatment parameters and the tumor volume, simple
linear regressions on tumor volume for each of the three
indices were performed. The estimates of the slopes and
their 95% confidence intervals were determined. Pear-
son's correlation coefficients and their 95% confidence
intervals were calculated for the whole cohort.
Results
Patient and tumor characteristics
The characteristics of the two treatment groups including
their gender, age, tumor histology and locations are
detailed below and summarized in Tables 1 and 2. The
simple group was composed predominantly of malignant
lesions and vestibular schwannomas, while the complex
group consisted primarily of cavernous sinus meningi-
omas and pituitary adenomas.
Overall radiosurgical parameters: effect of tumor shape
Overall, compared to previously reported conformity
indices for LINAC and GammaKnife systems, the Cyber-
Knife® radiosurgical system compared favorably with a
mean NCI of 1.6–1.8 and a mean HI of 1.2–1.3 (Table 3).
The standard percentage target coverage of 95% was not
compromised to obtain these values.
Base of skull lesions commonly have irregular, non-spher-
ical shapes due to the presence of dural tails and the anat-
omy of the region. To determine the effect of tumor shape
on radiosurgical parameters, a group of spherical cerebel-
lar and cerebral hemisphere metastases were analyzed for
comparison (Control Group II (metastases)). The calcu-
lated indices for this group were similar to the indices
obtained for the base of skull lesions: mean NCI of 1.73
and a mean HI of 1.21 (Table 3). These data suggest that
the CyberKnife® radiosurgical system generates conformal
and homogeneous plans independent of tumor shape.
HI
maximum dose
prescription dose
=
()
()
NCI
treatment volume prescription isodose volume
vol
=
× [( ) ( )]
(u ume of the target covered by the prescription isodose volu ume)2Radiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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Comparison of radiosurgical parameters between complex 
and simple base of skull lesions
Complex base of skull lesions were defined as one that
completely encircles, partially circumscribes, or directly
contacts the brainstem, optic chiasm, hypophysis, or cra-
nial nerves with meaningful remaining function (see Fig-
ure 1 for example). All other lesions were classified as
simple base of skull lesions (see Figure 2 for example).
Table 4 gives the distribution of tumor volume, homoge-
neity index, new conformity index, and percentage target
coverage for the simple and complex groups, respectively.
Overall, there is no statistically significant difference in
homogeneity index, new conformity index and percent-
age target coverage between the two groups at the 5%
level. There was a trend towards lower percent target cov-
erage in the complex group, however this was not statisti-
cally significant. These data suggest that the CyberKnife®
radiosurgical system generates acceptable plans independ-
ent of the proximity of adjacent critical structures to the
target volume.
Relationship between tumor volume and radiosurgical 
parameters
Previous radiosurgical series have shown that radiosurgi-
cal indices can be influenced by target volume [9]. In our
study, the mean tumor volumes differed significantly
between the simple and complex groups (p = 0.0059)
(Table 4). For the simple group, the mean tumor volume
was 45.6 cm3. The mean tumor volume for the complex
group was smaller at 12.5 cm3. Hence, we explored the
relationship between target volume and radiosurgical
indices using the CyberKnife® treatment planning system.
To assess the association between the three radiosurgical
treatment parameters (new conformity index, homogene-
ity index, and percentage of tumor coverage) and the tar-
get volume, scatterplots were constructed from the data
obtained from all skull base tumors (Figure 3, 4, 5).
Simple linear regressions on the tumor volume for each of
the three indices were then performed. The estimates of
the slopes are given in Table 5. The estimated slopes for all
indices are near zero. Pearson's correlation coefficients
were also calculated as seen in Table 5. All Pearson corre-
lation coefficients were less than ± 0.4 suggesting a poor
correlation between the examined variables. Therefore,
tumor volume does not appear to markedly effect radio-
surgical parameters when using the CyberKnife® radiosur-
gical treatment planning system in our patient
population.
Discussion
The CyberKnife® radiosurgical system has several advan-
tages over conventional radiosurgical systems. Cranial
Table 3: Radiosurgery Treatment Plan
Control Group I (simple) (n = 36) Control Group II (metastases) (n = 43) Study Group (complex) (n = 46)
Dose (cGy)
Min 900 1500 1500
Max 3500 3000 3500
Mean 2301 1905 2387
Median 2500 1900 2500
Treatment Stages
Min 3 1 1
Max 10 5 5
Mean 5.2 1.5 4.7
Median 5 1 5
Homogeneity Index
Min 1.11 1.11 1.07
Max 1.49 1.54 1.67
Mean 1.26 1.21 1.24
Median 1.25 1.19 1.25
New Conformity Index
Min 1.04 1.04 1.27
Max 2.59 3.11 2.27
Mean 1.66 1.73 1.67
Median 1.57 1.64 1.57
Percent Target Coverage (%)
Min 82.5 79.6 80.2
Max 99.9 100.0 99.9
Mean 95.9 97.0 94.3
Median 97.5 99.1 94.7Radiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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tracking, using skeletal anatomy to position the radiation
beam, is as precise as frame-based approaches and elimi-
nates the need for headframes [19]. In phantom studies,
the system's precision has been shown to compare favora-
bly to frame-based systems [20]. Its sub-millimeter clini-
cal accuracy is due both to improvements in radiation
delivery and target localization [21,22]. In addition, most
LINAC and Gamma Knife systems use forward planning
with user-selected arcs and beams. The CyberKnife® radio-
surgical system employs inverse planning algorithms
based on specific constraints to critical structures. In the-
ory, inverse planning should allow for easily obtainable,
optimized plans. The appropriate measure(s) of plan opti-
mization is still debated [9].
Assessment of success in radiosurgery requires time for
data to mature. But treatment-planning parameters,
including conformity and homgeneity, can be assessed
much earlier. In this study, we demonstrate that the
CyberKnife®  radiosurgical system generates plans with
excellent conformity and homogeneity. Theoretically,
improvements in conformity should improve local con-
trol and decrease complications in the treatment of skull
base lesions with adjacent critical structures. These general
principles have found acceptance in the treatment of other
sites with radiation therapy [23,24].
When irradiating complex skull base tumors that abut or
displace critical normal structures the dose constraints to
those normal structures may cause areas of under-dosing
within the target volume. Of particular concern is that the
resulting low dose regions within the tumor volume will
increase the rate of local failure. In two radiosurgical
series, the majority of local failures were due to tumor
progression just outside the prescribed isodose volume
[25,26]. At least one report in the literature has docu-
mented that increased conformity is paradoxically associ-
ated with poorer outcomes [27]. It has been suggested that
improved conformity may lead to underdosing micro-
scopic disease, not visible with current imaging modali-
ties. However, in the study cited above, the poorer
outcomes were likely due to the fact that conformity
improves with increasing size of the lesion and is not
related to an intrinsic and pure relationship between con-
formity and outcome. As logic dictates, increased rate of
local failure is predicted to be dependent on both the dose
minimum and the volume of this dose. Currently, percent
target coverage is used as a surrogate for quantifying these
(A) A 51 year old woman presented with progressive hearing loss Figure 1
(A) A 51 year old woman presented with progressive hearing loss. An axial MRI of the brain After gadolinium administration 
demonstrated a left cerebellopontine angle acoustic neuroma. (B) Planning CT scan with IV contrast. The patient was treated 
with 2500 cGy to the 79% isodose line in five stages.
1A 1BRadiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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low dose areas. In this study, percent target coverage was
maintained across all groups. Longer follow-up is
required to judge the effectiveness of this system in terms
of local tumor control.
Dose homogeneity is a second measure by which radio-
surgical plans are compared. The homogeneity index
(HI), the maximum dose within the target volume
divided by the prescription isodose (MDPD), is a com-
Table 4: Statistical Analysis
Control Group I (simple) (n = 36) Study Group (complex) (n = 46) Difference of the means (95% CI) p Value
Volume (cc)
Mean 45.61 12.60 --- 0.0059a
Median 8.83 7.27
Homogeneity Index
Mean 1.26 1.24 0.019 (-0.024, 0.063) 0.38a
Median 1.25 1.25
New Conformity Index
Mean 1.66 1.67 -0.007 (-0.155, 0.142) 0.93a
Median 1.57 1.57
Percent Target Coverage (%)
Mean 95.9 94.3 1.581 (-0.304, 3.466) 0.10b
Median 97.5 94.7
a = t-test
b = t-test for log transformed percent target coverage
(A) A 77 year old woman presented ten years after craniotomy for acoustic neuroma resection with deafness Figure 2
(A) A 77 year old woman presented ten years after craniotomy for acoustic neuroma resection with deafness. An axial MRI of 
the brain after gadolinium administration demonstrated radiographic progression of disease within the left internal acoustic 
meatus. (B) Planning CT scan with IV contrast. The patient was treated with 2500 cGy to the 84% isodose line in five stages.
2A 2BRadiation Oncology 2006, 1:46 http://www.ro-journal.com/content/1/1/46
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monly used measure of dose homogeneity. The impor-
tance of dose homogeneity in radiosurgical outcomes is
controversial. Inhomogeneous high central doses
achieved with some radiosurgical treatment systems may
provide improved local control [28]; however, this
increased local control may come with an increased risk of
neurologic complications [29]. A homogeneity index of
less than 2.0 is felt to balance the risk of local failure and
neurologic injury (RTOG guidelines) [28]. Homogeneity
indices less than 2.0 are especially important in treating
large tumors or tumors in close proximity to critical struc-
tures [29]. Even though we did not place limitations on
target volume or proximity of critical structures, we were
able to obtain homogeneity indices less than 2.0 for every
plan. Homogeneity of dose distributions for the Cyber-
Knife® was favorable compared with devices using multi-
ple isocenters which are typically 2.0. In the opinion of
the authors, allowable target volumes and proximity to
critical structures need to be determined in the context of
the homogeneity index. Larger target volumes and smaller
separation from critical structures may be acceptable for
systems that consistently generate low homogeneity indi-
ces [5].
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Percent target coverage versus volume scatter plot with cor- relation analysis Figure 5
Percent target coverage versus volume scatter plot with cor-
relation analysis.
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New conformity index versus volume scatter plot with cor- relation analysis Figure 3
New conformity index versus volume scatter plot with cor-
relation analysis.
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Homogeneity index versus volume scatter plot with correla- tion analysis Figure 4
Homogeneity index versus volume scatter plot with correla-
tion analysis.
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